| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |